Ohio State's 2014 ASH Review


Friday, January 31, 2014
The Ohio State University
Biomedical Research Tower, Room 115
460 W. 12th Ave.
Columbus, OH 43210
7:30 a.m. - 4:30 p.m.


The keynote speaker will be Kristie Blum, MD, associate professor in the Division of Hematology at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. Dr. Blum is an expert in novel therapies in lymphoma particularly ibrutinib and its use.

 

For primary care physicians, hematology and oncology specialists, researchers involved in hematology, nurses and other healthcare professionals
 

 Course Directors 

Steven Devine, MD​ Joseph Flynn, DO, MPH, FACP
Professor of Internal Medicine
Director, Blood and Marrow Transplant Program
The Ohio State University
Comprehensive Cancer Center​
James Cancer Hospital
and Solove Research Institute
Associate Professor of Clinical Internal Medicine
Co-Director, Division of Hematology
The Ohio State University
Comprehensive Cancer Center​
James Cancer Hospital
and Solove Research Institute
 

                                                                 


2014 ASH Review Presentations:

BTK Inhibition in Mantle Cell and Diffuse Large Cell Lymphoma: The Next Steps
Kristie A. Blum, MD
Associate Professor of Medicine
Section Head, OSU Lymphoma Program

What’s new in Chronic Lymphocytic Leukemia?
Jeffrey Jones, MD, MPH
Section Chief, CLL/HCL
Division of Hematology

ASH REVIEW-Lymphoma
Kami Maddocks, MD

Multiple Myeloma: ASH 2013
Ashley Rosko, MD

ASH Highlights in Acute Leukemia
Sumithira Vasu M.B.B.S.

MDS and MPD: ASH 2013
Katherine Walsh, MD

Benign Hematology
Tzu-Fei Wang, M.D.
Division of Hematology                                 

 

 

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu